Abiraterone pharmacokinetics were characterized by an extensive apparent clearance , which was lower in patients with mCRPC ( @,@ L/h ) versus healthy subjects ( @,@ L/h ) , and by large apparent central ( @,@ L ) and peripheral ( @,@ L ) volumes of distribution .